Mediators of Inflammation

Research Article

Response to Statin Therapy in Obstructive Sleep Apnea Syndrome: A Multicenter Randomized Controlled Trial

Table 2

Cardiovascular parameters at baseline (J0) and after 12 weeks (M3) of placebo or statin treatment.


	J0	M3	Change M3 − J0	Difference in change (95% CI)

PAT
Placebo ()				0.008 (−0.29; 0.28)
Statin ()				0.008 (−0.29; 0.28)
Carotid-to-femoral PWV (m/s)
Placebo ()				0.54 (−0.45; 1.52)
Statin ()				0.54 (−0.45; 1.52)
Right carotid IMT (m)
Placebo ()				0.02 (−70.38; 70.35)
Statin ()				0.02 (−70.38; 70.35)
Left carotid IMT (m)
Placebo ()				17.42 (−45.98; 80.81)
Statin ()				17.42 (−45.98; 80.81)
Mean carotid IMT (m)
Placebo ()				5.34 (−51.34; 62.02)
Statin ()				5.34 (−51.34; 62.02)
Right carotid luminal diameter (m)
Placebo ()				83 (−305; 472)
Statin ()		^$		83 (−305; 472)
Left carotid luminal diameter (m)
Placebo ()				−73 (−360; 215)
Statin ()				−73 (−360; 215)

Data are mean ± SD or percentage. PAT, peripheral arterial tone; PWV, pulse wave velocity; IMT, intima-media thickness. Analysis of data by repeated measure two-way ANOVA, followed by a Bonferroni post hoc test when necessary.
^$ for value visit.